University of Navarra tag sponsored by:
University of Navarra
-
CatalYm Reports Impressive and Lasting Responses Including Multiple Complete Responses in Heavily Pretreated, Late- to Last-Line Metastatic NSCLC, Urothelial and Hepatocellular Cancer Patients Treated with Visugromab / Nivolumab Combination – Catalym
catalym.com | | Article Details | Related Articles